Literature DB >> 30279811

Clinicopathological features of bi-ventricular cardiac intimal sarcoma-Report of an autopsy case.

Takehiro Tamaki1, Makoto Suzuki1, Ryuta Umezu1, Yuko Utanohara1, Keitaro Mahara1, Shuichiro Takanashi2, Tatsuya Murai3, Hitonobu Tomoike1.   

Abstract

We present the clinicopathological characteristics of primary cardiac intimal sarcoma which was widely spread throughout bi-ventricles. The patient had a wide range of clinical manifestations starting with left-sided heart failure then finally developing refractory right-sided heart failure during 44 months of follow-up. <Learning objective: The present clinicopathological characteristics with a wide spectrum of clinical features may provide a pivotal insight into understanding primary cardiac intimal sarcoma.>.

Entities:  

Keywords:  Clinicopathology; Heart failure; Intimal sarcoma; Primary cardiac tumor; Valvular heart disease

Year:  2017        PMID： 30279811      PMCID： PMC6149639          DOI： 10.1016/j.jccase.2017.06.001

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN： 1878-5409


  8 in total

1.  Surgical Treatment of Primary Cardiac Sarcomas: Review of a Single-Institution Experience.

Authors:  Basel Ramlawi; Monika J Leja; Walid K Abu Saleh; Odeaa Al Jabbari; Robert Benjamin; Vinod Ravi; Oz M Shapira; Shanda H Blackmon; Brian A Bruckner; Michael J Reardon
Journal:  Ann Thorac Surg       Date:  2015-10-21       Impact factor: 4.330

2.  Coactivated platelet-derived growth factor receptor {alpha} and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma.

Authors:  Barbara Dewaele; Giuseppe Floris; Julio Finalet-Ferreiro; Christopher D Fletcher; Jean-Michel Coindre; Louis Guillou; Pancras C W Hogendoorn; Agnieszka Wozniak; Vanessa Vanspauwen; Patrick Schöffski; Peter Marynen; Peter Vandenberghe; Raf Sciot; Maria Debiec-Rychter
Journal:  Cancer Res       Date:  2010-08-04       Impact factor: 12.701

3.  Undifferentiated intimal sarcoma of large systemic blood vessels: report of 14 cases with immunohistochemical profile and review of the literature.

Authors:  Matjaz Sebenik; Andrew Ricci; Bruno DiPasquale; Kokila Mody; Peter Pytel; Kowan Ja Jee; Sakari Knuutila; John Scholes
Journal:  Am J Surg Pathol       Date:  2005-09       Impact factor: 6.394

Review 4.  The 2015 WHO Classification of Tumors of the Heart and Pericardium.

Authors:  Allen Burke; Fabio Tavora
Journal:  J Thorac Oncol       Date:  2015-12-25       Impact factor: 15.609

5.  Successful treatment of pulmonary artery sarcoma by a two-drug combination chemotherapy consisting of ifosfamide and epirubicin.

Authors:  Akiko Uchida; Masahiro Tabata; Katsuyuki Kiura; Yasushi Tanimoto; Arihiko Kanehiro; Motoi Aoe; Nobuya Ohohara; Hiroshi Ueoka; Mitsune Tanimoto
Journal:  Jpn J Clin Oncol       Date:  2005-06-23       Impact factor: 3.019

6.  Cardiac autotransplantation for malignant or complex primary left-heart tumors.

Authors:  Shanda H Blackmon; Ashish R Patel; Brian A Bruckner; Erik A Beyer; David C Rice; Ara A Vaporciyan; Zbigniew Wojciechowski; Arlene M Correa; Michael J Reardon
Journal:  Tex Heart Inst J       Date:  2008

7.  Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas.

Authors:  Agnès Neuville; Françoise Collin; Patrick Bruneval; Marie Parrens; Françoise Thivolet; Anne Gomez-Brouchet; Philippe Terrier; Vincent Thomas de Montpreville; François Le Gall; Isabelle Hostein; Pauline Lagarde; Frédéric Chibon; Jean-Michel Coindre
Journal:  Am J Surg Pathol       Date:  2014-04       Impact factor: 6.394

8.  Primary cardiac sarcomas: a retrospective study of the French Sarcoma Group.

Authors:  Nicolas Isambert; Isabelle Ray-Coquard; Antoine Italiano; Maria Rios; Pierre Kerbrat; Mélanie Gauthier; Aurélien Blouet; Loïc Chaigneau; Florence Duffaud; Sophie Piperno-Neumann; Jean-Emmanuel Kurtz; Nicolas Girard; Olivier Collard; Emmanuelle Bompas; Nicolas Penel; Jacques-Olivier Bay; Cécile Guillemet; Françoise Collin; Jean-Yves Blay; Axel Le Cesne; Juliette Thariat
Journal:  Eur J Cancer       Date:  2013-10-14       Impact factor: 9.162
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.